{"id":"https://openalex.org/W4281607040","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.8003","title":"Phase 1 study of CART-ddBCMA in relapsed or refractory multiple myeloma.","display_name":"Phase 1 study of CART-ddBCMA in relapsed or refractory multiple myeloma.","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4281607040","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.8003"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.8003","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.8003","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.8003","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064556004","display_name":"Matthew J. Frigault","orcid":"https://orcid.org/0000-0002-6774-5694","observed_orcids":["https://orcid.org/0000-0002-6774-5694"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew J. Frigault","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054346063","display_name":"Jacalyn M. Rosenblatt","orcid":"https://orcid.org/0000-0001-5582-8161","observed_orcids":["https://orcid.org/0000-0001-5582-8161"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacalyn Rosenblatt","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA;","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114029895","display_name":"Daniella Cook","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniella Cook","raw_affiliation_strings":["Massachusetts General Hospital, Charlestown, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Charlestown, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ha Na Cho","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ha Na Cho","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080842569","display_name":"Gabriel D. Depinho","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriel D. Depinho","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085692402","display_name":"Emma K. Logan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emma Logan","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston, MA;","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113708869","display_name":"Jessica J. Liegel","orcid":"https://orcid.org/0009-0007-8014-706X","observed_orcids":["https://orcid.org/0009-0007-8014-706X"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica Liegel","raw_affiliation_strings":["Beth Israel Deaconess, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess, Boston, MA;","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047220807","display_name":"Yougeesh Prabhakar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yougeesh Prabhakar","raw_affiliation_strings":["David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL;","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055128977","display_name":"Christine Cornwell","orcid":"https://orcid.org/0000-0003-3185-9347","observed_orcids":["https://orcid.org/0000-0003-3185-9347"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christine Cornwell","raw_affiliation_strings":["Arcellx, Gaithersburg, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arcellx, Gaithersburg, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046952743","display_name":"Kamalika C Banerjee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kamalika Banerjee","raw_affiliation_strings":["Arcellx, Gaithersburg, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arcellx, Gaithersburg, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065261953","display_name":"Anand Rotte","orcid":"https://orcid.org/0000-0002-3452-7068","observed_orcids":["https://orcid.org/0000-0002-3452-7068"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anand Rotte","raw_affiliation_strings":["Arcellx, Gaithersburg, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arcellx, Gaithersburg, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104929572","display_name":"Christopher Ryan Heery","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108253","display_name":"Precision BioSciences (United States)","ror":"https://ror.org/01pvdcq70","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108253"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Ryan Heery","raw_affiliation_strings":["Precision Biosciences, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Biosciences, Durham, NC;","institution_ids":["https://openalex.org/I4210108253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052641327","display_name":"David Avigan","orcid":"https://orcid.org/0000-0003-4624-6017","observed_orcids":["https://orcid.org/0000-0003-4624-6017"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Avigan","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston, MA;","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057911528","display_name":"Andrzej J. Jakubowiak","orcid":"https://orcid.org/0000-0002-2597-6822","observed_orcids":["https://orcid.org/0000-0002-2597-6822"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrzej J. Jakubowiak","raw_affiliation_strings":["University of Chicago, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL;","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089893290","display_name":"Michael Russell Bishop","orcid":"https://orcid.org/0000-0002-3979-9273","observed_orcids":["https://orcid.org/0000-0002-3979-9273"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Russell Bishop","raw_affiliation_strings":["David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL;","institution_ids":["https://openalex.org/I40347166"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"8003","last_page":"8003"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.913100004196167,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.913100004196167,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.08330000191926956,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.777999997138977},{"id":"https://openalex.org/keywords/b-cell-maturation-antigen","display_name":"BCMA","score":0.9399999976158142},{"id":"https://openalex.org/keywords/relapsed-refractory-multiple-myeloma","display_name":"relapsed/refractory multiple myeloma","score":0.953000009059906},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.6370000243186951},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.781000018119812},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.902999997138977},{"id":"https://openalex.org/keywords/immune-effector-cell-associated-neurotoxicity-syndrome","display_name":"immune effector cell-associated neurotoxicity syndrome","score":0.949999988079071},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.7739999890327454},{"id":"https://openalex.org/keywords/extramedullary-disease","display_name":"extramedullary disease","score":0.6759999990463257},{"id":"https://openalex.org/keywords/fludarabine-and-cyclophosphamide","display_name":"fludarabine and cyclophosphamide","score":0.7919999957084656}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9218690395355225},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6189952492713928},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6155661344528198},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.5840415954589844},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5600115656852722},{"id":"https://openalex.org/C2778524551","wikidata":"https://www.wikidata.org/wiki/Q7227206","display_name":"Pomalidomide","level":4,"score":0.5181397199630737},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5161669850349426},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.4735250473022461},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.45661893486976624},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.44959747791290283},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4378204643726349},{"id":"https://openalex.org/C2777275308","wikidata":"https://www.wikidata.org/wiki/Q234668","display_name":"Cart","level":2,"score":0.4374878704547882},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.404911607503891},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.40376153588294983},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3763412833213806},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3186551332473755},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2533692717552185},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.8003","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.8003","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.8003","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4310107703","https://openalex.org/W4389233643","https://openalex.org/W4295817443","https://openalex.org/W4224440688","https://openalex.org/W3095496494","https://openalex.org/W2606328008","https://openalex.org/W4389247978","https://openalex.org/W2947402055","https://openalex.org/W4409255688","https://openalex.org/W2924578117"],"abstract_inverted_index":{"8003":[0],"Background:":[1],"Chimeric":[2],"Antigen":[3],"Receptor":[4],"(CAR)":[5],"T":[6,33],"cell":[7,34],"therapies":[8],"targeting":[9],"B-cell":[10],"maturation":[11],"antigen":[12],"(BCMA)":[13],"have":[14,84,353,375,487],"demonstrated":[15,465],"benefit":[16],"in":[17,274,291,302,309,340,349,409,418,423,456,491],"patients":[18],"(pts)":[19],"with":[20,81,173,196,215,267,286,332,351,358,389,431,471,493],"relapsed":[21],"and/or":[22],"refractory":[23],"Multiple":[24],"Myeloma":[25],"(RRMM).":[26],"CART-ddBCMA":[27,112,460],"is":[28,58,69,96,141],"an":[29],"autologous":[30],"anti-BCMA":[31],"CAR":[32],"therapy":[35,95,210],"that":[36],"utilizes":[37],"a":[38,44,48,70,203],"novel,":[39],"synthetic":[40],"binding":[41],"domain,":[42],"called":[43],"D-Domain,":[45],"instead":[46],"of":[47,54,65,136,143,157,188,205,209,270,293,304,345,370,380,435,446,450,473,477],"typical":[49],"scFv":[50],"binder.":[51],"The":[52,138,314],"objective":[53],"this":[55,341,410],"first-in-human":[56],"trial":[57,78,496],"to":[59,109,328,462],"assess":[60],"the":[61,383,395,413,444],"safety":[62,181,235],"and":[63,103,111,124,155,168,175,182,236,296,322,397,402,438,475,479],"efficacy":[64,183,243],"CART-ddBCMA.":[66],"Methods:":[67],"This":[68],"Phase":[71],"1,":[72],"multi-center,":[73],"open":[74],"label,":[75],"dose":[76,384],"escalation":[77,118,385],"for":[79,180,234,242,366],"pts":[80,193,227,246,277,348,374,386,416,453,492],"RRMM":[82],"who":[83],"received":[85,194],"\u22653":[86,272],"prior":[87,207],"regimens":[88],"or":[89],"are":[90,153],"triple-refractory.":[91],"After":[92],"apheresis,":[93],"bridging":[94],"allowed":[97],"during":[98],"manufacturing.":[99],"Pts":[100,172],"receive":[101],"fludarabine":[102],"cyclophosphamide":[104],"(30/300":[105],"mg/m2/day)":[106],"days":[107,308],"-5":[108],"-3":[110],"infusion":[113],"on":[114],"day":[115],"0.":[116],"Dose":[117],"was":[119,221,400],"performed":[120],"at":[121,364,443],"100":[122],"(DL1)":[123],"300":[125],"(DL2)":[126],"x":[127],"106":[128],"(\u00b1":[129],"20%)":[130],"CAR+T":[131],"cells,":[132],"followed":[133],"by":[134],"expansion":[135],"DL1.":[137,275],"primary":[139],"endpoint":[140],"incidence":[142],"adverse":[144],"events":[145],"(AEs),":[146],"including":[147,212,429,468,490],"dose-limiting":[148],"toxicities":[149],"(DLTs).":[150],"Additional":[151],"endpoints":[152],"depth":[154],"duration":[156,434],"response":[158,379],"(IMWG":[159],"Criteria),":[160],"minimal":[161],"residual":[162],"disease":[163,217],"(MRD,":[164],"clonoSEQ),":[165],"progression-free":[166],"(PFS)":[167],"overall":[169],"survival":[170],"(OS).":[171],"1-":[174],"3-months":[176],"follow-up":[177,220],"were":[178,232,264,440],"eligible":[179],"analysis,":[184],"respectively.":[185,481],"Results:":[186],"As":[187],"January":[189],"25,":[190],"2022,":[191],"25":[192,226],"CART-ddBCMA,":[195],"median":[197,204],"age":[198],"66":[199],"(range:":[200],"44-76),":[201],"after":[202],"5":[206,347],"lines":[208],"(3-16),":[211],"10":[213],"(40%)":[214],"extramedullary":[216],"(EMD).":[218],"Median":[219,433],"9.8":[222],"(2-23.7)":[223],"months.":[224],"Overall,":[225,368],"(19":[228],"DL1;":[229,239],"6":[230,240,415],"DL2)":[231,241,254],"evaluable":[233,373,442,452],"24":[237,451],"(18":[238],"analysis.":[244],"All":[245,260],"experienced":[247,278],"CRS,":[248],"but":[249],"only":[250],"1":[251,287],"pt":[252],"(in":[253],"had":[255],"grade":[256],"(gr)":[257],"3":[258,289,430],"CRS.":[259],"other":[261],"CRS":[262,273],"cases":[263,269,311],"gr":[265,271,281,284,288],"\u22642,":[266],"no":[268],"Four":[276],"ICANS":[279],"(2,":[280],"\u22642;":[282],"2,":[283],"3),":[285],"case":[290],"each":[292],"DL1":[294,350],"(5%)":[295],"DL2":[297],"(17%).":[298],"Standard":[299],"management":[300],"resulted":[301],"resolution":[303],"CRS/ICANS":[305],"within":[306],"30":[307],"all":[310],"without":[312],"sequelae.":[313],"ORR":[315,396,470],"=":[316,320,325,393],"100%,":[317],"sCR/CR":[318],"rate":[319,324,399],"67%,":[321],"\u2265VGPR":[323,476],"88%.":[326],"Conversion":[327],"CR/sCR":[329,398,474],"has":[330,464],"occurred":[331],"longer":[333],"follow-up,":[334,357,391],"as":[335,337],"late":[336],"month":[338],"9":[339,355],"trial.":[342],"At":[343],"time":[344,445],"data-cut":[346,447],"PR/VGPR":[352],"<":[354],"months":[356,486],"4":[359,361,420],"(of":[360],"evaluable)":[362],"negative":[363],"\u226510-5":[365],"MRD.":[367],"17":[369],"20":[371],"(85%)":[372],"achieved":[376],"best":[377],"MRD":[378],"\u226510-5.":[381],"In":[382],"(i.e.,":[387],"those":[388],"longest":[390],"n":[392],"12),":[394],"100%":[401,469],"75%,":[403],"respectively,":[404],"despite":[405],"58%":[406],"(7/12)":[407],"EMD":[408],"group.":[411],"Of":[412],"first":[414],"dosed":[417],"DL1,":[419],"(67%)":[421],"continue":[422],"ongoing":[424,457],"sCR":[425],"beyond":[426,484],"18":[427,485],"months,":[428],"EMD.":[432,494],"response,":[436],"PFS":[437],"OS":[439],"not":[441],"because":[448],"19":[449],"(79%)":[454],"remain":[455],"response.":[458],"Conclusions:":[459],"administration,":[461],"date,":[463],"clinical":[466],"activity,":[467],"rates":[472],"67%":[478],"88%,":[480],"Durable":[482],"responses":[483],"been":[488],"observed,":[489],"Clinical":[495],"information:":[497],"NCT04155749.":[498]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2022-06-12T00:00:00"}